Models
BLUE JET HEALTHCARE LTDBLUEJETPharmaceuticals & Biotechnology
₹152per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model₹152implied FY26 P/E 11.2× · EV/EBITDA 8.8×
Against CMP ₹569.95−73.3%close of 2026-09-10
Growth the CMP implies45.0%revenue, a year for 5 years, on your other inputs
Value after FY3169%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.
Where the methods land · ₹ per share · the dashed line is the CMP
DCF, rate ±1 · growth ±1your model across the sensitivity grid
₹122₹213
52-week rangetraded range, a fact not a value
₹325₹723
From enterprise to equity · ₹ crore
| PV of FY27–FY31 free cash flow | 804 |
| PV of terminal value | 1,777 |
| Enterprise value | 2,581 |
| less net debt | 61 |
| less non-controlling interest | 0 |
| add non-operating investments | 0 |
| Equity value | 2,642 |
| ÷ 17.35 crore shares | ₹152 |
Free cash flow, filed and modelled · ₹ '000 crore
Filed, cash from operations − capexModelled free cash flow to firm
Sensitivity · ₹ per share
Down Across| WACC ↓terminal growth → | 4.0% | 4.5% | 5.0% | 5.5% | 6.0% |
|---|---|---|---|---|---|
| 10.00% | 157 | 167 | 179 | 194 | 213 |
| 10.50% | 146 | 155 | 165 | 177 | 191 |
| 11.00% | 137 | 144 | 152 | 162 | 174 |
| 11.50% | 129 | 135 | 142 | 150 | 160 |
| 12.00% | 122 | 127 | 133 | 140 | 148 |
The outlined cell is your model. Green figures sit above the CMP of ₹569.95; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.
Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together
| 10th · 50th · 90th percentile, ₹ per share | 132 · 152 · 177 |
| Draws below the CMP | 100% |
| Rank correlation with discount rate | −0.76 |
| Rank correlation with ebitda margin | +0.63 |
| Rank correlation with revenue growth | −0.03 |
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.
Projected cash flow to the firm · ₹ crore
History Forward| ₹ crore | FY24 | FY25 | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 712 | 1,030 | 947 | 900 | 855 | 812 | 772 | 733 |
| growth % | — | 44.7 | (8.0) | (5.0) | (5.0) | (5.0) | (5.0) | (5.0) |
| EBITDA | 219 | 378 | 294 | 279 | 265 | 252 | 239 | 227 |
| margin % | 30.8 | 36.7 | 31.0 | 31.0 | 31.0 | 31.0 | 31.0 | 31.0 |
| less depreciation | (28) | (18) | (24) | (22) | (21) | (20) | (19) | (18) |
| EBIT | 191 | 360 | 270 | 256 | 244 | 231 | 220 | 209 |
| less tax on EBIT | (69) | (65) | (62) | (59) | (56) | (53) | ||
| NOPAT | 201 | 191 | 182 | 172 | 164 | 156 | ||
| add depreciation | 28 | 18 | 24 | 22 | 21 | 20 | 19 | 18 |
| less capex | (173) | (80) | 0 | 0 | (6) | (12) | (17) | (22) |
| less working-capital build | — | 23 | 22 | 21 | 20 | 19 | ||
| Free cash flow to firm | 68 | (34) | — | 237 | 219 | 202 | 186 | 171 |
| Discount factor | 0.949 | 0.855 | 0.770 | 0.694 | 0.625 | |||
| Present value | 225 | 187 | 155 | 129 | 107 |
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.
The three statements, projected · ₹ crore · debt held at 0, dividends at 8.4% of profit
| ₹ crore | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| EBIT | 270 | 256 | 244 | 231 | 220 | 209 |
| Interest at 8% on debt | 0 | 0 | 0 | 0 | 0 | |
| Profit before tax | 256 | 244 | 231 | 220 | 209 | |
| Profit after tax | 248 | 191 | 182 | 172 | 164 | 156 |
| Dividends | (21) | (16) | (15) | (14) | (14) | (13) |
| Balance sheet, year end | ||||||
| Cash | 61 | 282 | 485 | 673 | 845 | 1,003 |
| Working capital | 470 | 446 | 424 | 402 | 382 | 363 |
| Net block and other assets | 1,111 | 1,088 | 1,073 | 1,065 | 1,063 | 1,067 |
| Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity | 1,360 | 1,535 | 1,701 | 1,859 | 2,009 | 2,152 |
| Balance check | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow | ||||||
| From operations | 237 | 225 | 214 | 203 | 193 | |
| Investing (capex) | 0 | (6) | (12) | (17) | (22) | |
| Financing (dividends) | (16) | (15) | (14) | (14) | (13) | |
| Net change in cash | 221 | 204 | 187 | 172 | 158 | |
| Free cash flow to equity | 237 | 219 | 202 | 186 | 171 | |
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.
Scenarios side by side · ₹ per share
| Scenario | Template | Growth | Margin | Rate | Terminal | ₹ / share | vs CMP |
|---|---|---|---|---|---|---|---|
| Base · editing | DCF | -5% | 31% | 11.00% | 5% | ₹152 | (73.3)% |
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.